TipRanks on MSN2d
Sutro Biopharma Prioritizes ADC Programs Amid Financial Shift
Sutro Biopharma ( ($STRO) ) has released its Q4 earnings. Here is a breakdown of the information Sutro Biopharma presented to its investors. Sutro ...
BioSpace2d
Sutro Cuts Half of Staff, Deprioritizes ADC in Strategic Review
Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate ...
Fierce Biotech2d
Sutro discards CEO, 50% of staff, sole clinical-stage ADC and manufacturing site to save cash
Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its manufacturing facility in a major bid to save cash.
Fierce Biotech3d
Sotio takes up option on ADCs, while Boehringer inks GPCR discovery pact
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate in Taiwan" award. This recognition follows OBI Pharma’s ...
Pharmaceutical Technology on MSN4d
WuXi XDC and AbTis collaborate on antibody-drug conjugates
The partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and ...
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western studyFast Track Designation granted by FDA for CRB-701 to ...